Derma Sciences’ MEDIHONEY ® product line is the leading brand of honey-based dressings for the management of wounds and burns. The product has been shown in clinical studies to be effective in ...

Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, announces receipt of the CE Mark for ...

Resources. Webinars; Fierce Events; Industry Events; Podcasts; Survey; Subscribe ...

Natural healthcare products company Comvita is to buy Australian firm Medihoney in an $A6 million deal.

Medihoney is the safe and natural choice to take care of your wound and skincare needs. All products in the Comvita Medihoney range contain Medihoney Antibacterial Manuka Honey.

Healthcare & Pharmaceuticalscategory Trump healthcare price transparency order may not bring intended relief to patients 10:31 AM UTC Healthcare & Pharmaceuticalscategory Exclusive: FDA staff ...

The study found that in 49 patients randomized to receive MEDIHONEY or standard dressings following microvascular free tissue reconstruction for cancer of the head and neck, the median duration of ...

Comvita has sold its Medihoney brand to US partner Derma Sciences for about $19 million, and will reap a further $11m selling shares.

We’re sorry, this feature is currently unavailable. We’re working to restore it. Please try again later. Dismiss ...

Medihoney products challenge the reliance on synthetic medicines and treatments and provide a natural alternative for wound and skin care, suitable for use by the whole family.